| Literature DB >> 34413590 |
Dilip Shirly Arjun1, Sham S Bhat1, Sundeep K Hegde1, Vidya S Bhat1, Hejamady Tati Ajay Rao1, Shenoy S Ramdas1.
Abstract
PURPOSE: The current in vitro study was conducted to assess the remineralization potential of CPP-ACP and a customized dentifrice (tricalcium-phosphate) on artificial carious lesions using DIAGNOdent.Entities:
Keywords: Casein phosphopeptide-amorphous calcium phosphate; Customized dentifrice; DIAGNOdent; Remineralization
Year: 2021 PMID: 34413590 PMCID: PMC8343688 DOI: 10.5005/jp-journals-10005-1937
Source DB: PubMed Journal: Int J Clin Pediatr Dent ISSN: 0974-7052
Intragroup comparison assessing the difference at various intervals to check the level of significance using Wilcoxon sign rank test
| Demineralization—Baseline | −3.65 | <0.001[ | −3.7 | <0.001[ | −3.65 | <0.001[ |
| 15 days—Baseline | −3.65 | <0.001[ | −3.67 | <0.001[ | −3.66 | <0.001[ |
| 30 days—Baseline | −3.65 | <0.001[ | −3.66 | <0.001[ | −3.65 | <0.001[ |
| 15 days—Demineralization | −3.54 | <0.001[ | −3.56 | <0.001[ | −1 | 0.32 (NS) |
| 30 days—Demineralization | −3.64 | <0.001[ | −3.66 | <0.001[ | −1.41 | 0.16 (NS) |
| 30 days—15 days | −3.43 | 0.001[ | −3.45 | 0.001[ | −1 | 0.32 (NS) |
p < 0.05 statistically significant, p > 0.05 non-significant, NS
Intergroup comparison at various intervals using Kruskal–Wallis test
| Baseline | Group I | 17 | 3.53 (1.13) | 1–5 | 4 (3–4) | 0.40 | 0.82 (NS) |
| Group II | 17 | 3.59 (1.06) | 2–5 | 4 (3–4.5) | |||
| Group III | 17 | 3.41 (0.71) | 2–4 | 4 (3–4) | |||
| Demineralization | Group I | 17 | 14.35 (2.09) | 8–16 | 15 (14–16) | 2.47 | 0.29 (NS) |
| Group II | 17 | 13.65 (2.18) | 7–16 | 14 (13.5–15) | |||
| Group III | 17 | 13.59 (2.72) | 6–16 | 14 (13.5–15) | |||
| 15 days | Group I | 17 | 11.53 (1.46) | 7–13 | 12 (11–12.5) | 17.75 | <0.001[ |
| Group II | 17 | 11.29 (1.80) | 6–13 | 12 (11–12) | |||
| Group III | 17 | 13.53 (2.70) | 6–16 | 14 (13.5–15) | |||
| 30 days | Group I | 17 | 8.47 (1.28) | 7–11 | 8 (7.5–9) | 22.41 | <0.001[ |
| Group II | 17 | 8.94 (1.35) | 6–12 | 9 (8–9.5) | |||
| Group III | 17 | 13.47 (2.74) | 6–16 | 14 (13.5–15) | |||
p < 0.05 statistically significant, p > 0.05 non-significant, NS
Intergroup comparison of variables at different time intervals using Mann–Whitney U test
| Group I vs group II | U Statistic | 143.50 | 102.00 | 138.50 | 108.00 |
| 0.97 (NS) | 0.13 (NS) | 0.83 (NS) | 0.19 (NS) | ||
| Group I vs group III | U Statistic | 128.50 | 113.50 | 42.00 | 28.00 |
| 0.55 (NS) | 0.27 (NS) | <0.001[ | <0.001[ | ||
| Group II vs group III | U Statistic | 130.50 | 133.00 | 40.00 | 31.50 |
| 0.61 (NS) | 0.68 (NS) | <0.001[ | <0.001[ |
p < 0.05 statistically significant, p > 0.05 non-significant, NS
| Tricalcium phosphate | 21 g |
| Bentonite | 750 mg |
| Sodium lauryl sulfate | 125 mg |
| Saccharin sodium | 125 mg |
| Methyl salicylate | 0.125 mL (4 drops) |
| Peppermint oil | 0.12 mL (4 drops) |
| Mucilage of acacia | 3.5 mL |
| Glycerin | 7.5 mL |